Search for Clinical Trial Results
Anemia, Sickle Cell - 31 Studies Found
| Status | Study |
| Terminated |
Study Name: Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository) Condition: Anemia, Sickle Cell Date: 2007-09-10 |
| Completed |
Study Name: Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease Condition: Sickle Cell Disease Date: 2010-03-25 |
| Completed |
Study Name: PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease Condition: Sickle Cell Disease Date: 2006-06-21 Interventions: Drug: L-citrulline tablets, 1000 mg |
| Completed |
Study Name: Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease Condition: Sickle Cell Disease Date: 2009-05-27 Interventions: Drug: GMI-1070 Intravenous GMI-1070 given as two doses over the course of one day |
| Completed |
Study Name: Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) Condition: Sickle Cell Disease Date: 2015-05-27 Interventions: Other: SCD Group No Intervention. Use of discard blood/tissue |
| Completed |
Study Name: Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients Condition: Pulmonary Hypertension Date: 2009-12-01 |
| Completed |
Study Name: Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) Condition: Pain Date: 2016-09-01 Interventions: Device: SMART app wearable Patients will be given a wearable such as a Microsoft Band accelerometer to t |
| Completed |
Study Name: Fresh Versus Old Red Blood Cells for Transfusion Condition:
Date: 2011-03-18 Interventions:
|
| Completed |
Study Name: Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A Condition: Infections, Streptococcal Date: 2010-08-03 Interventions:
|
| Completed |
Study Name: Siplizumab for Sickle Cell Disease Transplant Condition: Anemia, Sickle Cell Date: 2026-01-10 Interventions: Premedication with diphenhydramine 50 mg PO is to be given 1 hour prior to siplizumab infusion.Premedication with hydrocortisone succinate 100 m |